Login / Signup

Comorbidity and frailty assessment in renal cell carcinoma patients.

Jean CourcierAlexandre De La TailleNathalie LassauAlexandre Ingels
Published in: World journal of urology (2021)
Comorbidity and frailty have to be assessed at any stage of the RCC disease based on a standardized scoring system to define the most suitable treatment strategy ranging from surveillance to aggressive treatment.
Keyphrases
  • renal cell carcinoma
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • smoking cessation
  • patient reported